Reference : Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Functio...
Scientific congresses and symposiums : Poster
Human health sciences : Hematology
http://hdl.handle.net/2268/162323
Eculizumab (ECU) Inhibits Thrombotic Microangiopathy (TMA) and Improves Renal Function In Adult Patients (Pts) With Atypical Hemolytic Uremic Syndrome (aHUS)
English
Fakhouri, Fadi [Hôpital Necker - Enfants Malades, Paris, France > > > > >]
Hourmant, Maryvonne [CHU Hôtel Dieu-Nantes, Nantes, France > > > >]
Cataland, Spero [The Ohio State University, Columbus, OH > Internal Medicine > > >]
Espinosa, Mario [Hospital Universitario Reine Sofia, Cordoba, Spain > > Nephrologia > >]
Gaber, Osama A. [Methodist Hospital, Houston > > > >]
Menne, Jan [Hannover Medical School, Hannover, Germany > Nephrology and Hypertension > > >]
Minetti, Enrico [Azienda Ospedaliero Niguarda Ca'Granda, Milano, Italy > Nephrology, Dialysis, Transplantation > > >]
Provot, François [CHU Lille, Lille, France > Nephrology > > >]
Rondeau, Eric [Hôpital Tenon, Assistance Publique Hôpitaux de Paris, Paris, > > > >]
Ruggenenti, Piero [Aldo e Cele Dacco of the Mario Negri, Institute of Pharma, Bergamo, Italy > > > >]
WEEKERS, Laurent mailto [Centre Hospitalier Universitaire de Liège - CHU > > Néphrologie >]
Ogawa, Masayo [Alexion Pharmaceuticals, Inc, Cheshire, CT > > > >]
Bedrosian, Camille [Alexion Pharmaceuticals, Inc, Cheshire, CT > > > >]
Legendre, Christophe [Université Paris Descartes and Hôpital Necker, Paris, France > > > >]
8-Dec-2013
Yes
No
International
55th ASH Annual Meeting and Exposition
du 7 au 10 décembre 2013
ASH, American Society of Hematology
New Orleans, LA
USA
[en] Eculizumab ; Thrombotic microangiopathy ; Atypical Hemolytic Uremic Syndrome ; aHUS
Researchers ; Professionals
http://hdl.handle.net/2268/162323

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Eculizumab.pdfPublisher postprint146.36 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.